Health Condition 1: null- chief complaint of dysmenorrhoea with scanty or average amount of menses, along with or without associated symptoms and dysmenorrhoea since more than 2 consecutive cycles.
Conditions
Interventions
Intervention1: Vijayadi Vati: Group A:
Minimum 50 patients of Kashatartava will be treated by Vijayadi Vati orally.
Dose - 500mg twice a day with lukewarm water.
Duration - Drug will be started 5 days
Sponsors
National Institute of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient coming with chief complaint of dysmenorrhoea with scanty or average amount of menses. 2. Patient in age group of 16 to 30 years. 3. Patient having H/O dysmenorrhoea along with or without associated symptoms. 4. Patient suffering from dysmenorrhoea since more than 2 consecutive cycles.
Exclusion criteria
Exclusion criteria: 1. Patient having any organic pathology of uterus and adnexae. 2. HIV, VDRL, HBsAg positive patient. 3. Patient suffering from systemic diseases. 4. Patient with Intra uterine contraceptive devices. 5. Patient with menorrhagia and metrorrhagia. 6. Patient having menstrual period interval less than 21 days or more than 35 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain assessment on Visual Analog Scale Numeric Rating ScaleTimepoint: 1. First follow up is done during trial after Second menses. 2.Final outcome is assessed after completion of trial in the next consecutive menses. | — |
Secondary
| Measure | Time frame |
|---|---|
| nausea, vomiting, giddiness, constipation, breast tenderness, diarrhea, headache, faintingTimepoint: 1. First follow up is done during trial after Second menses. 2.Final outcome is assessed after completion of trial in the next consecutive menses. | — |
Countries
India
Contacts
Public ContactDr Priyanka Sharma
National Institute of Ayurveda
Outcome results
None listed